The Oncology Institute, Inc., listed under ticker DFPH, filed an 8-K with the Securities and Exchange Commission on May 7, 2026. The company entered public markets through its business combination with DFB Healthcare Acquisitions Corp, a healthcare-focused blank-check company sponsored by DFB Healthcare Sponsors LLC that completed its IPO in 2020. Operating in the oncology and value-based cancer care sector, The Oncology Institute provides community-based cancer treatment services across multiple U.S. markets. The May 2026 filing represents a continuing post-merger disclosure event under its SEC reporting obligations. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on DFPH and hundreds of other SPAC transactions.